The patient’s anaemia is complex and could have multiple causes. The anaemia is microcytic/normocytic and is accompanied by normal ferritin levels and elevated TIBC. However, the patient also has polymyalgia rheumatica, an inflammatory disorder that can affect ferritin levels. Ferritin is an acute-phase reactant and can be elevated in inflammation, making it an unreliable measurement.

Iron-deficient anaemia typically presents as microcytic with high TIBC levels. The high TIBC is due to the body’s ability to transport iron despite low iron levels. Iron-deficient anaemia also has low ferritin levels, but this may not be the case in this patient due to their chronic inflammatory condition. Therefore, iron-deficient anaemia is the most likely diagnosis due to the high TIBC levels.

Anaemia of chronic disease is also normocytic but typically has low or normal TIBC levels. This is because iron is trapped in inflammatory tissue and not available for use, reducing the body’s ability to transport free iron.

B12 deficiency results in macrocytic anaemia, which is not the case in this patient. Haemolytic anaemia is a rare form of anaemia that results in normocytic anaemia and does not explain the abnormalities in iron studies seen in this patient.

Iron Studies: Understanding the Different Tests

Iron studies are a group of laboratory tests that help evaluate a person’s iron status. These tests include serum iron, total iron binding capacity (TIBC), transferrin, transferrin saturation, and ferritin. Serum iron measures the amount of iron in the blood, while TIBC measures the amount of iron that can bind to transferrin, a protein that transports iron in the blood. Transferrin saturation is calculated by dividing serum iron by TIBC, and it reflects the percentage of transferrin that is saturated with iron. Ferritin, on the other hand, is a protein that stores iron in the body, and its level in the blood can indicate the amount of iron stored in the body.

In iron deficiency anaemia (IDA), the levels of serum iron and transferrin saturation are low, while TIBC and transferrin are high. Ferritin levels are also low in IDA. However, in pregnancy and in the presence of oestrogen, transferrin levels may be elevated. Inflammatory disorders, on the other hand, can cause an increase in ferritin levels.

Other rarer tests that may be used to evaluate iron status include transferrin receptors, which are increased in IDA, and tests for anaemia of chronic disease, which is a normochromic/hypochromic, normocytic anaemia characterized by reduced serum and TIBC levels and normal or raised ferritin levels. Understanding these different tests can help healthcare providers diagnose and manage iron-related disorders.

Blood Donation Eligibility Criteria: Factors to Consider

When it comes to donating blood, there are several factors to consider to ensure the safety of both the donor and the recipient. Here are some examples:

Recent travel to an endemic area: If a person has recently traveled to a country with a high risk of infectious diseases, they may have to wait a certain period before donating blood. For instance, if someone has returned from Nigeria, they must wait at least six months before donating blood in the UK.

Underweight: A person must weigh at least 50 kg to donate blood. If they weigh less than that, they may not have enough blood volume to spare.

Body piercing: If someone has had a body piercing within the last 12 months, they should inform the staff before donating blood. They may have to wait for at least four months before donating.

Tattoo: Similarly, if someone has had a tattoo within the last 12 months, they should inform the staff before donating blood. They may have to wait for at least four months before donating.

Age: To donate blood, a person must be between 17 and 66 years old (or 70 if they have donated blood before). If they are over 70, they can still donate if they have donated blood in the last two years.

By considering these factors, blood donation centers can ensure that the blood they collect is safe and suitable for transfusion.

Eye Infections and Inflammations: Symptoms and Differences

Eye infections and inflammations can cause a range of symptoms, but it is important to differentiate between them to ensure appropriate treatment. Here are some common eye conditions and their distinguishing features:

Orbital Cellulitis: This is a serious condition that can cause erythema (redness) around the eye, pain on eye movements, restricted eye movements, proptosis (bulging of the eye), reduced visual acuity, and a relative afferent pupillary defect (RAPD). It is usually caused by the spread of infection from sinuses or trauma to the orbit. Treatment involves antibiotics and surgery if there is an orbital collection.

Conjunctivitis: This is a common condition that can accompany upper respiratory tract infections. It causes redness and discharge from the eye, but does not usually cause proptosis, restricted eye movements, or a RAPD.

Anterior Uveitis: This is an inflammation of the iris and ciliary body that causes a painful red eye, photophobia, increased lacrimation, and blurred vision. It does not usually cause erythema or proptosis.

Preseptal Cellulitis: This is a less serious condition that causes swelling and erythema of the eyelid, but does not cause proptosis, visual changes, or a RAPD. It is often confused with orbital cellulitis, but can be differentiated by the absence of these symptoms.

Blepharitis: This is an inflammation of the eyelid that causes swelling, erythema, and flakiness or scaliness of the eyelids. It does not usually cause proptosis or visual changes.

The patient has raised liver transaminases, thrombocytosis, neutrophilia, raised antistreptolysin titres, and a reduced estimated glomerular filtration rate (eGFR). The most probable diagnosis is glandular fever/infectious mononucleosis caused by the Epstein-Barr virus (EBV). This infection is common in adolescents and presents with a prolonged sore throat, lethargy, and flu-like symptoms. Splenomegaly or hepatosplenomegaly, along with lymphadenopathy, are often observed. Liver function tests, especially the transaminases, are commonly elevated during active infection. Thrombocytopenia is commonly associated with glandular fever due to splenic involvement. Neutrophilia is less likely in this case than lymphocytosis, which is common with glandular fever. Antistreptolysin titres rise after a streptococcal infection, but glandular fever is a more likely diagnosis than streptococcal infection. Reduced eGFR associated with a sore throat should raise suspicion of dehydration or glomerulonephritis caused by a streptococcal infection, but neither of these diagnoses is as likely as glandular fever. The diagnostic investigation of choice for glandular fever is the Monospot test, which tests for heterophile antibodies to EBV.

Ankylosing spondylitis is associated with several features that can be remembered using the acronym ‘A’s. These include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, and amyloidosis. However, achalasia is not a known association with ankylosing spondylitis.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).

This question assesses the candidate’s understanding of TIA risk stratification. The individual meets the criteria for crescendo TIAs, having experienced two TIAs within a week. This necessitates prompt evaluation and imaging. Admission is recommended for any patient with a score of more than 4 on the ABCD2 scale or crescendo TIA.

A transient ischaemic attack (TIA) is a brief period of neurological deficit caused by a vascular issue, lasting less than an hour. The original definition of a TIA was based on time, but it is now recognized that even short periods of ischaemia can result in pathological changes to the brain. Therefore, a new ’tissue-based’ definition is now used. The clinical features of a TIA are similar to those of a stroke, but the symptoms resolve within an hour. Possible features include unilateral weakness or sensory loss, aphasia or dysarthria, ataxia, vertigo, or loss of balance, visual problems, and sudden transient loss of vision in one eye (amaurosis fugax).

NICE recommends immediate antithrombotic therapy with aspirin 300 mg unless the patient has a bleeding disorder or is taking an anticoagulant. If the patient has had more than one TIA or has a suspected cardioembolic source or severe carotid stenosis, specialist review is necessary. Urgent assessment is required within 24 hours for patients who have had a suspected TIA in the last 7 days. Referral for specialist assessment is necessary as soon as possible within 7 days for patients who have had a suspected TIA more than a week previously. Neuroimaging and carotid imaging are recommended, and antithrombotic therapy is necessary. Carotid artery endarterectomy should only be considered if the carotid stenosis is greater than 70% according to ECST criteria or greater than 50% according to NASCET criteria.

Primary sclerosing cholangitis is often associated with ulcerative colitis.

Crohn’s disease and ulcerative colitis are the two main types of inflammatory bowel disease with many similarities in symptoms and management options. However, there are key differences such as non-bloody diarrhea and upper gastrointestinal symptoms being more common in Crohn’s disease, while bloody diarrhea and abdominal pain in the left lower quadrant are more common in ulcerative colitis. Complications and pathology also differ between the two diseases.

Hypersensitivity Reactions: Types and Examples

Hypersensitivity reactions are immune responses that can cause tissue damage and inflammation. There are four types of hypersensitivity reactions, each with different mechanisms and clinical presentations.

Type I hypersensitivity reaction is an immediate hypersensitivity reaction mediated by IgE in response to an innocuous environmental antigen. Examples of such reactions are allergic rhinitis and systemic urticaria.

Type II hypersensitivity reaction is an antibody-mediated reaction. Cellular injury may result from complement activation, antibody-dependent cell-mediated cytotoxicity or phagocytosis. Examples include incompatible blood transfusions, haemolytic disease of the newborn and autoimmune haemolytic anaemias.

Type III hypersensitivity reaction is an immune complex-mediated reaction. Immune complexes are lattices of antibody and antigen. When these are not cleared from the circulation, they may trigger an inflammatory response. An example of this type of reaction is extrinsic allergic alveolitis, otherwise known as ‘bird fancier’s lung’, a hypersensitivity pneumonitis caused by exposure to bird droppings.

Type IV hypersensitivity reaction is a delayed hypersensitivity reaction involving T helper cells that become activated upon contact with an antigen, which results in a clonal expansion over 1–2 weeks. Repeated exposure to the antigen results in cytokine release from sensitised T-cells, leading to macrophage-induced phagocytosis.

Anaphylaxis is a type I-mediated hypersensitivity reaction, involving the release of inflammatory mediators (such as histamine), which precipitate vasodilatation and oedema. Anaphylaxis is characterised by the rapid onset of respiratory and circulatory compromise.

Understanding the different types of hypersensitivity reactions is important for diagnosis and treatment. Treatment may involve removal of the source of hypersensitivity, immunosuppressive therapy, or administration of epinephrine in the case of anaphylaxis.

For cancer patients with VTE, the recommended treatment is a DOAC for a period of 6 months. Among the DOACs, apixaban is the most suitable option as it has been found to have a lower risk of bleeding complications compared to LMWH and VKA. Moreover, patients taking apixaban can benefit from oral treatment and avoid frequent monitoring required with other anticoagulation treatments. Studies have also shown that apixaban is the most cost-effective option as it results in fewer bleeds.

NICE updated their guidelines on the investigation and management of venous thromboembolism (VTE) in 2020. The use of direct oral anticoagulants (DOACs) is recommended as first-line treatment for most people with VTE, including as interim anticoagulants before a definite diagnosis is made. Routine cancer screening is no longer recommended following a VTE diagnosis. The cornerstone of VTE management is anticoagulant therapy, with DOACs being the preferred choice. All patients should have anticoagulation for at least 3 months, with the length of anticoagulation being determined by whether the VTE was provoked or unprovoked.

Cyanosis, a bluish discoloration of the skin, is a common occurrence in newborns. Peripheral cyanosis, which affects the hands and feet, is often seen in the first 24 hours of life and can be caused by crying or illness. Central cyanosis, on the other hand, is a more serious condition that occurs when the concentration of reduced hemoglobin in the blood exceeds 5g/dl. To differentiate between cardiac and non-cardiac causes of central cyanosis, doctors may use the nitrogen washout test, which involves giving the infant 100% oxygen for ten minutes and then measuring arterial blood gases. A pO2 of less than 15 kPa indicates cyanotic congenital heart disease, which can be caused by conditions such as tetralogy of Fallot, transposition of the great arteries, and tricuspid atresia.

If cyanotic congenital heart disease is suspected, initial management involves supportive care and the use of prostaglandin E1, such as alprostadil, to maintain a patent ductus arteriosus in ductal-dependent congenital heart defects. This can serve as a temporary measure until a definitive diagnosis is made and surgical correction is performed.

Acrocyanosis, a type of peripheral cyanosis, is a benign condition that is often seen in healthy newborns. It is characterized by bluish discoloration around the mouth and extremities, such as the hands and feet, and is caused by vasomotor changes that result in peripheral vasoconstriction and increased tissue oxygen extraction. Unlike other causes of peripheral cyanosis that may indicate significant pathology, such as septic shock, acrocyanosis occurs immediately after birth in healthy infants and typically resolves within 24 to 48 hours.

While salmonella can cause diarrhoea, typhoid fever is more likely to result in constipation. This is a typical symptom of typhoid fever, along with the appearance of rose spots. It’s important to note that constipation can be a significant indicator of this illness. In contrast, Campylobacter jejuni infection usually causes bloody diarrhoea and abdominal pain. E. coli is a common cause of watery diarrhoea, but certain strains like E. coli O157:H7 can lead to severe abdominal cramping, vomiting, and bloody diarrhoea. Giardiasis can cause similar symptoms such as bloating and abdominal pain, but it usually results in chronic diarrhoea. Shigellosis typically causes abdominal pain and diarrhoea, which may or may not be bloody.

Enteric fever, also known as typhoid or paratyphoid, is caused by Salmonella typhi and Salmonella paratyphi respectively. These bacteria are not normally found in the gut and are transmitted through contaminated food and water or the faecal-oral route. The symptoms of enteric fever include headache, fever, and joint pain, as well as abdominal pain and distension. Constipation is more common in typhoid than diarrhoea, and rose spots may appear on the trunk in some patients. Complications can include osteomyelitis, gastrointestinal bleeding or perforation, meningitis, cholecystitis, and chronic carriage. Chronic carriage is more likely in adult females and occurs in approximately 1% of cases.

Latex allergy often presents as a Type I hypersensitivity reaction, which can lead to anaphylaxis. In such cases, it is crucial to administer adrenaline promptly and follow standard anaphylaxis management protocols.

Classification of Hypersensitivity Reactions

Hypersensitivity reactions are classified into four types according to the Gell and Coombs classification. Type I, also known as anaphylactic hypersensitivity, occurs when an antigen reacts with IgE bound to mast cells. This type of reaction is responsible for anaphylaxis and atopy, such as asthma, eczema, and hay fever. Type II, or cytotoxic hypersensitivity, happens when cell-bound IgG or IgM binds to an antigen on the cell surface. This type of reaction is associated with autoimmune hemolytic anemia, ITP, Goodpasture’s syndrome, and other conditions. Type III, or immune complex hypersensitivity, occurs when free antigen and antibody (IgG, IgA) combine to form immune complexes. This type of reaction is responsible for serum sickness, systemic lupus erythematosus, post-streptococcal glomerulonephritis, and extrinsic allergic alveolitis. Type IV, or delayed hypersensitivity, is T-cell mediated and is responsible for tuberculosis, graft versus host disease, allergic contact dermatitis, and other conditions.

In recent times, a fifth category has been added to the classification of hypersensitivity reactions. Type V hypersensitivity occurs when antibodies recognize and bind to cell surface receptors, either stimulating them or blocking ligand binding. This type of reaction is associated with Graves’ disease and myasthenia gravis. Understanding the different types of hypersensitivity reactions is important in diagnosing and treating various conditions. Proper identification of the type of reaction can help healthcare professionals provide appropriate treatment and management strategies.

For reducing the risk of stroke in patients with atrial fibrillation (AF), the first-line anticoagulation should be a direct oral anticoagulant (DOAC) such as rivaroxaban. This recommendation is based on a scenario where a patient is found to have AF during a wellbeing check and requires anticoagulation due to the increased risk of thrombosis. Aspirin is not the correct choice as it is an antiplatelet and not an anticoagulant. While dalteparin and enoxaparin are low molecular weight heparins that are often used for VTE prophylaxis, DOACs are preferred first-line for stroke risk reduction in AF. Patients often prefer DOACs as they are available in tablet form.

NICE recommends using the CHA2DS2-VASc score to determine the need for anticoagulation in patients with any history of AF. The ORBIT scoring system should be used to assess bleeding risk, but anticoagulation should not be withheld solely on the grounds of age or risk of falls. DOACs are now recommended as the first-line anticoagulant for patients with AF, with warfarin used second-line if a DOAC is contraindicated or not tolerated. Aspirin is not recommended for reducing stroke risk in patients with AF.

Understanding Abdominal Aortic Aneurysms

Abdominal aortic aneurysms occur when the elastic proteins within the extracellular matrix fail, causing dilation of all layers of the arterial wall. This degenerative disease is most commonly seen in individuals over the age of 50, with diameters of 3 cm or greater considered aneurysmal. The development of aneurysms is a complex process involving the loss of the intima and elastic fibers from the media, which is associated with increased proteolytic activity and lymphocytic infiltration.

Smoking and hypertension are major risk factors for the development of aneurysms, while rare causes include syphilis and connective tissue diseases such as Ehlers Danlos type 1 and Marfan’s syndrome. It is important to understand the pathophysiology of abdominal aortic aneurysms in order to identify and manage risk factors, as well as to provide appropriate treatment for those affected. By recognizing the underlying causes and risk factors, healthcare professionals can work to prevent the development of aneurysms and improve outcomes for those affected.

For a suspected case of epididymo-orchitis in a high-risk patient for sexually transmitted infections (STI), such as this young businessman returning from Thailand, the recommended empirical treatment is ceftriaxone 500mg intramuscularly single dose, plus oral doxycycline 100mg twice daily for 10-14 days. This is because the likely organisms involved are Chlamydia trachomatis and Neisseria gonorrhoeae. If the clinical scenario suggests gram-negative organisms, as in the case of an older man with low risk of STI, ciprofloxacin 500mg twice daily for 10-14 days can be used as empirical treatment. However, amoxicillin, metronidazole, and clarithromycin are not suitable antibiotics to cover the possible organisms and are not recommended in the guidelines.

Epididymo-orchitis is a condition where the epididymis and/or testes become infected, leading to pain and swelling. It is commonly caused by infections spreading from the genital tract or bladder, with Chlamydia trachomatis and Neisseria gonorrhoeae being the usual culprits in sexually active younger adults, while E. coli is more commonly seen in older adults with a low-risk sexual history. Symptoms include unilateral testicular pain and swelling, with urethral discharge sometimes present. Testicular torsion, which can cause ischaemia of the testicle, is an important differential diagnosis and needs to be excluded urgently, especially in younger patients with severe pain and an acute onset.

Investigations are guided by the patient’s age, with sexually transmitted infections being assessed in younger adults and a mid-stream urine (MSU) being sent for microscopy and culture in older adults with a low-risk sexual history. Management guidelines from the British Association for Sexual Health and HIV (BASHH) recommend ceftriaxone 500mg intramuscularly as a single dose, plus doxycycline 100mg orally twice daily for 10-14 days if the organism causing the infection is unknown. Further investigations are recommended after treatment to rule out any underlying structural abnormalities.

Possible Diagnoses for a Patient with Thrombocytopenia, Deep Vein Thrombosis, Recurrent Miscarriages, and Chorea

Antiphospholipid Syndrome:
Antiphospholipid syndrome is a disorder characterized by the presence of antiphospholipid antibodies that cause thrombosis and recurrent miscarriages. The patient’s symptoms of deep vein thrombosis, three spontaneous miscarriages, and chorea are consistent with this diagnosis. The blood test shows thrombocytopenia, which is also a common finding in antiphospholipid syndrome. The diagnosis requires a positive test on at least two occasions, 6 weeks apart, in one or more of the antiphospholipid antibody assays. Treatment involves lifelong anticoagulation with warfarin in patients with a history of thrombosis.

Uncontrolled Epilepsy:
The patient’s explosive jerky movements of the limbs may indicate poorly controlled epilepsy. However, this diagnosis does not explain all of her other symptoms.

Idiopathic Thrombocytopenic Purpura (ITP):
ITP is a disorder that causes a low platelet count and a characteristic purpuric rash. However, the absence of a rash and the multitude of other clinical signs make a diagnosis of ITP insufficient to explain the patient’s presentation.

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH):
SIADH is a disorder that causes water retention and hyponatremia. However, the patient’s symptoms do not fit with this diagnosis.

Dehydration:
Severe dehydration may present with postural hypotension and an increased risk of deep vein thrombosis. However, dehydration alone cannot explain the patient’s other symptoms.

Conclusion:
Based on the patient’s clinical features, antiphospholipid syndrome is the most likely diagnosis. Further testing is needed to confirm the diagnosis and determine the appropriate treatment plan.

Puberty: Normal Changes in Males and Females

Puberty is a natural process that marks the transition from childhood to adulthood. In males, the first sign of puberty is testicular growth, which typically occurs around the age of 12. A testicular volume greater than 4 ml indicates the onset of puberty. The maximum height spurt for males occurs at the age of 14.

For females, the first sign of puberty is breast development, which typically occurs around the age of 11.5. The height spurt for females reaches its maximum early in puberty, at the age of 12, before menarche. Menarche, the onset of menstruation, typically occurs at the age of 13.

Following menarche, there is only a small increase of about 4% in height. It is important to note that normal changes in puberty may include gynaecomastia in boys, asymmetrical breast growth in girls, and diffuse enlargement of the thyroid gland. These changes are a natural part of the process and should not cause alarm. Understanding the normal changes that occur during puberty can help individuals navigate this important stage of development with confidence.

Medications to Avoid in Patients with Heart Failure

Heart failure is a serious condition that requires careful management of medications. Some medications can exacerbate heart failure and should be avoided. Thiazolidinediones, such as pioglitazone, are contraindicated as they cause fluid retention. Verapamil has a negative inotropic effect and should be used with caution. NSAIDs and glucocorticoids can also cause fluid retention and should be used with caution. However, low-dose aspirin is an exception as many patients with heart failure also have coexistent cardiovascular disease and the benefits of taking aspirin easily outweigh the risks. Class I antiarrhythmics, such as flecainide, have a negative inotropic and proarrhythmic effect and should be avoided. It is important for healthcare providers to be aware of these medications and to carefully consider their use in patients with heart failure.

Irritable bowel syndrome (IBS) is a gastrointestinal disorder that causes abdominal pain, bloating, and changes in bowel habits without any identifiable organic pathology. It is more common in women and can be worsened by stress and the perimenstrual period. Diagnosis is made by ruling out other potential causes of symptoms. Management includes dietary changes, such as increasing fiber intake and avoiding trigger foods, as well as psychological support. Medications may also be used to alleviate symptoms. This patient’s symptoms are not consistent with chronic pancreatitis, ulcerative colitis, peptic ulcer disease, or diverticulitis.

Understanding Different Types of Headaches

Headaches are a common ailment that can be caused by a variety of factors. Here are some of the different types of headaches and their distinguishing characteristics:

1. Tension headache: This type of headache is often described as a tight, band-like pain across the forehead and is more common in females. It typically worsens towards the end of the day but does not interfere with daily activities. Chronic tension headaches occur at least 15 days of the month for at least three months.

2. Brain tumour: Headaches caused by space-occupying lesions tend to be worse in the morning and when bending forward. They may also be associated with vomiting.

3. Cluster headache: This type of headache is more common in men and presents with intense pain localized around one eye, which can last for a few minutes up to three hours. There may also be simultaneous lacrimation and nasal congestion. Symptoms occur every day or multiple times every day for a number of weeks, followed by a symptom-free period lasting months or even years.

4. Giant cell arteritis: This type of headache typically occurs in those aged over 50 years and is characterized by an abrupt onset and recurrent daily headache. Common symptoms include scalp pain/tenderness, jaw claudication, visual disturbances, fever, weight loss, and lethargy. A diagnosis of GCA requires three out of five specific criteria.

5. Migraine: Migraines can occur daily but are typically accompanied by associated features such as nausea or vomiting, photophobia, or phonophobia. The International Headache Society criteria for migraine without aura include at least five attacks fulfilling specific criteria.

Understanding the different types of headaches and their characteristics can help in proper diagnosis and treatment.

Frontotemporal dementia (FTD) is a rare form of dementia that typically affects younger patients, with onset between 55 and 65 years old. Unlike Alzheimer’s disease, early memory impairment is not a characteristic symptom of FTD. Instead, early personality and behavior changes are core features. Consensus guidelines suggest diagnostic criteria that include insidious onset and gradual progression, decline in social interpersonal conduct, early impairment in regulation of personal conduct, early emotional blunting, and early loss of insight. Supportive diagnostic features may include behavioral disorders, speech and language changes, and physical signs. Other forms of dementia, such as Alzheimer’s disease, diffuse Lewy body disease (LBD), multiple sclerosis (MS), and vascular dementia, have different characteristic symptoms and diagnostic criteria.

Carbimazole: Side Effects and Mechanism of Action

Carbimazole is a medication used to treat hyperthyroidism by inhibiting the production of thyroid hormones. However, it can also cause several side effects that patients should be aware of.

The most serious side effect is bone marrow suppression, which can lead to neutropenia and agranulocytosis. Patients should report any symptoms of infection immediately, as routine monitoring of white cell count is not useful. Cholestatic jaundice and drug-induced hepatitis are also possible side effects, but usually reversible upon discontinuation of the drug. Hypoprothrombinaemia, a rare side effect, can increase the risk of bleeding in patients on anticoagulant therapy.

Carbimazole works by inhibiting the enzyme thyroperoxidase, which is responsible for the synthesis of thyroid hormones. However, its onset of clinical effects is slow because it takes time to deplete the large store of pre-formed thyroid hormones in the thyroid gland.

In addition to its anti-thyroid effect, carbimazole also has a modest immunosuppressive activity, reduces the serum level of thyroid-stimulating hormone antibody, and can cause a reduction in clotting factor prothrombin. However, these effects are not thought to contribute significantly to its efficacy.

Overall, patients taking carbimazole should be aware of its potential side effects and report any symptoms to their healthcare provider promptly.

The routine use of non-invasive ventilation in asthmatics is not supported by current guidelines.

Management of Acute Asthma

Acute asthma is classified by the British Thoracic Society (BTS) into three categories: moderate, severe, and life-threatening. Patients with any of the life-threatening features should be treated as having a life-threatening attack. A fourth category, Near-fatal asthma, is also recognized. Further assessment may include arterial blood gases for patients with oxygen saturation levels below 92%. A chest x-ray is not routinely recommended unless the patient has life-threatening asthma, suspected pneumothorax, or failure to respond to treatment.

Admission criteria include a previous near-fatal asthma attack, pregnancy, an attack occurring despite already using oral corticosteroid, and presentation at night. All patients with life-threatening asthma should be admitted to the hospital, and patients with features of severe acute asthma should also be admitted if they fail to respond to initial treatment. Oxygen therapy should be started for hypoxaemic patients. Bronchodilation with short-acting beta₂-agonists (SABA) is recommended, and all patients should be given 40-50mg of prednisolone orally daily. Ipratropium bromide and IV magnesium sulphate may also be considered for severe or life-threatening asthma. Patients who fail to respond require senior critical care support and should be treated in an appropriate ITU/HDU setting. Criteria for discharge include stability on discharge medication, checked and recorded inhaler technique, and PEF levels above 75% of best or predicted.

Diagnostic Tests for Lower Limb Ischaemia

Lower limb ischaemia is a medical emergency that requires prompt diagnosis and treatment. Several diagnostic tests can be used to determine the cause and severity of the condition. Here are some of the most common tests:

1. Lower limb angiography: This test can identify the site of arterial occlusion and help plan the appropriate treatment, such as embolectomy or fasciotomy.
2. Focused assessment with sonography for trauma (FAST) scan of the abdomen: This test is useful in cases of trauma or suspected abdominal aortic aneurysm rupture.
3. Ankle-brachial pressure index (ABPI): This quick and easy test can provide an early indication of the severity of ischaemia. A value of 0.9-1.2 is considered normal, while values below 0.3 indicate critical ischaemia.
4. Echocardiogram: This test can rule out a cardiac source of embolisation, but lower limb angiography is the priority in cases of acute ischaemia.
5. Lower limb Doppler: This test can be used to assess arterial or venous flow, depending on the suspected cause of ischaemia.

In summary, a combination of these diagnostic tests can help diagnose and treat lower limb ischaemia effectively.

The 2014 NICE guidelines recommend using the QRISK2 tool to identify patients over 40 years old who are at high risk of CVD, with a 10-year risk of 10% or greater. A full lipid profile should be checked before starting a statin, and atorvastatin 20mg should be offered first-line. Lifestyle modifications include a cardioprotective diet, physical activity, weight management, limiting alcohol intake, and smoking cessation. Follow-up should occur at 3 months, with consideration of increasing the dose of atorvastatin up to 80 mg if necessary.

Tests for Helicobacter pylori

There are several tests available to diagnose Helicobacter pylori infection. One of the most common tests is the urea breath test, where patients consume a drink containing carbon isotope 13 (13C) enriched urea. The urea is broken down by H. pylori urease, and after 30 minutes, the patient exhales into a glass tube. Mass spectrometry analysis calculates the amount of 13C CO2, which indicates the presence of H. pylori. However, this test should not be performed within four weeks of treatment with an antibacterial or within two weeks of an antisecretory drug.

Another test is the rapid urease test, also known as the CLO test. This involves mixing a biopsy sample with urea and a pH indicator. If there is a color change, it indicates the presence of H. pylori urease activity. Serum antibody tests can also be used, but they remain positive even after eradication. Culture of gastric biopsy can provide information on antibiotic sensitivity, while histological evaluation alone can be done through gastric biopsy. Lastly, the stool antigen test has a sensitivity of 90% and specificity of 95%.

Overall, these tests have varying levels of sensitivity and specificity, and the choice of test depends on the patient’s clinical presentation and the availability of resources.

The patient requires a CT head scan within an hour of the accident, as per NICE guidelines. A basal skull fracture, which can be fatal, may be caused by high-impact mechanisms and can present with symptoms such as bruising behind the ear, bruising around the eyes, blood behind the eardrum, or cerebral spinal fluid rhinorrhoea. Optic-nerve entrapment may also occur if the fracture is displaced, leading to changes in vision. Patients are at an increased risk of developing meningitis. An MRI head is not the primary investigation of choice for acute clinically important brain injuries due to safety, logistic, and resource reasons. A lateral cervical spine X-ray may be required for a thorough assessment of the C-spine, but a CT head and neck would be easier to perform if imaging of the neck is necessary. A plain skull X-ray may be used for non-accidental brain injury in children to avoid high-dose radiation from a CT scan, but it should not be used to diagnose brain trauma without consulting a neuroscience unit. If red flags are present, a CT head is necessary to exclude severe intracranial pathology.

The appropriate medical treatments for postpartum haemorrhage caused by uterine atony are oxytocin, ergometrine, carboprost, and misoprostol. In this scenario, the patient has experienced a blood loss of over 500 ml after delivery, indicating PPH as the likely cause, with uterine atony being the most probable reason. The first steps in managing PPH involve an ABCDE approach, including IV access, warm crystalloid administration, uterine fundus palpation, and catheterisation to prevent bladder distention. If these measures fail, medical therapy is initiated, starting with IV oxytocin. IM carboprost is not the correct choice as it requires senior approval and can worsen bronchoconstriction in patients with asthma. IV carboprost is also not recommended as it can cause bronchospasm, hypertension, and fever, and requires senior approval. IV tocolytics are not appropriate as they suppress uterine contractions, which would exacerbate the problem in this case. Therefore, agents that stimulate uterine contraction are given to manage PPH caused by uterine atony.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.

In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.

Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.

The management of asthma in adults has been updated by NICE in 2017, following the 2016 BTS guidelines. One of the significant changes is in ‘step 3’, where patients on a SABA + ICS whose asthma is not well controlled should be offered a leukotriene receptor antagonist instead of a LABA. NICE does not follow the stepwise approach of the previous BTS guidelines, but to make the guidelines easier to follow, we have added our own steps. The steps range from newly-diagnosed asthma to SABA +/- LTRA + one of the following options, including increasing ICS to high-dose, a trial of an additional drug, or seeking advice from a healthcare professional with expertise in asthma. Maintenance and reliever therapy (MART) is a form of combined ICS and LABA treatment that is only available for ICS and LABA combinations in which the LABA has a fast-acting component. It should be noted that NICE does not recommend changing treatment in patients who have well-controlled asthma simply to adhere to the latest guidance. The definitions of what constitutes a low, moderate, or high-dose ICS have also changed, with <= 400 micrograms budesonide or equivalent being a low dose, 400 micrograms - 800 micrograms budesonide or equivalent being a moderate dose, and > 800 micrograms budesonide or equivalent being a high dose for adults.

Assessing Ankle Injuries: Indications for X-rays

When evaluating a patient with ankle pain, the Ottawa Rules can be used to determine if an X-ray is necessary. These rules have a high sensitivity for excluding fractures and can be applied to patients between the ages of three and 55. Bony tenderness at the navicular meets the criteria for an X-ray. However, bruising of the toes or non-tender swelling over the lateral malleolus do not necessarily require an X-ray. Inability to weight bear for four steps or tenderness at the base of the fifth metatarsal may indicate the need for an X-ray. Treatment for uncomplicated fractured toes involves neighbour strapping.